Press release
Retinoblastoma Market Expands with Precision Therapies & Asia-Pacific Growth | Pfizer Inc., Bristol Myers Squibb Company, Teva Pharmaceutical Pvt Ltd., Merck and Co., Novartis AG
Retinoblastoma Market
Retinoblastoma Market Report by DataM Intelligence offers a detailed assessment of the global pediatric oncology landscape, highlighting market size, key players, and critical growth drivers. With advances in localized therapeutics, improved early-detection protocols, and supportive ocular-preservation strategies, the report delivers strategic insights for stakeholders from 2025 to 2033.
In 2025, oncolytic-virus approaches showed promise. Theriva Bio presented Phase-1 VCN-01 data at ASCO showing encouraging responses in refractory vitreous seeds and the U.S. regulator granted fast-track status to novel AAV gene therapy candidates for inherited retinal disease, signalling accelerated attention to gene/oncolytic strategies in pediatric ocular cancers.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/retinoblastoma-market?ophp
Retinoblastoma Market Competitors Overview:
Pfizer Inc., Bristol Myers Squibb Company, Teva Pharmaceutical Pvt Ltd., Merck and Co., Novartis AG, GlaxoSmithKline Plc, Johnson & Johnson, Baxter International, Inc., AbbVie Inc., and Hikma Pharmaceuticals Plc among others.
Important Industry Updates:
In August 2024, Theriva Biologics Inc. received an FDA-granted rare pediatric drug designation for VCN-01 as a treatment for pediatric patients with retinoblastoma.
In July 2023, the FDA approved a new drug application (NDA) for 200-mg/mL vials of cyclophosphamide injection for use in combination therapy for the treatment of various cancers including retinoblastoma. The approval is expected to demonstrate the safety and efficacy of the product and help the company broaden the available treatment options.
Methodology and Scope
The Retinoblastoma Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/retinoblastoma-market?ophp
Retinoblastoma Market Segments Overview:
By Disease Type (Laterality, Inheritance), By Treatment (Surgery, Radiation Therapy, Cryotherapy, Laser Therapy, Chemotherapy, Others), By End-User (Hospitals, Ophthalmic Clinics, Cancer Research Centers, Others)
Regional Overview for Retinoblastoma Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=retinoblastoma-market
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the Retinoblastoma market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Retinoblastoma market?
Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Retinoblastoma Market Expands with Precision Therapies & Asia-Pacific Growth | Pfizer Inc., Bristol Myers Squibb Company, Teva Pharmaceutical Pvt Ltd., Merck and Co., Novartis AG here
News-ID: 4142687 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Controlled Release Drug Delivery Market to Reach US$ 92.7 Billion …
Controlled Release Drug Delivery Market Overview
The global controlled release drug delivery market reached an estimated value of US$ 52.4 billion in 2024 and is projected to reach US$ 92.7 billion by 2033, growing at a CAGR of 6.7% during the forecast period 2025-2033. The market is driven by the increasing demand for advanced drug delivery technologies that enhance therapeutic efficacy, minimize side effects, and improve patient compliance. Controlled release drug…
United States Agricultural Drone Market to hit USD 36,546.21 Million by 2032, Gr …
Global Agricultural Drone Market reached USD 2,943.23 million in 2024 and is projected to witness lucrative growth by reaching up to USD 36,546.21 million by 2032. The market is expected to exhibit a CAGR of 37.01% during the forecast period (2025-2032).
Agricultural drones are revolutionizing modern farming by enabling precise, data-driven crop management. Equipped with advanced sensors, multispectral cameras, and GPS technology, these drones provide real-time insights into crop…
3D Concrete Printing Market to hit Multi-Billion Valuation by 2031, Growing at 6 …
3D Concrete Printing Market is expected to grow at a CAGR of 61.82% during the forecast period 2024-2031.
3D concrete printing is transforming the construction industry by enabling faster, more precise, and highly customizable building processes. Using automated layer-by-layer deposition of specially formulated concrete, this technology reduces material waste, lowers labor requirements, and accelerates project timelines. It supports the creation of complex architectural designs, affordable housing, and sustainable infrastructure with…
United States Herbal Supplements Market to Reach CAGR 6.2% by 2031 | Rising Dema …
Herbal Supplements Market Overview
The global herbal supplements market is projected to grow at a CAGR of 6.2% during the forecast period 2024-2031, driven by increasing consumer interest in natural health products, preventive healthcare, and alternative medicine. Herbal supplements are derived from plants or plant components used for their flavor, aroma, or medicinal properties, and are commonly available in forms such as tablets, capsules, powders, teas, extracts, and fresh or dried…
More Releases for Retinoblastoma
Retinoblastoma Treatment Market Trends That Will Shape the Next Decade: Insights …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Retinoblastoma Treatment Market Size By 2025?
Sizing up the retinoblastoma treatment sector reveals a robust expansion trend over the past few years; projections indicate a rise from its $2.03 billion valuation in 2024 to $2.15 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma is a rare pediatric eye cancer that originates in the retina and primarily affects children under five years of age. It accounts for around 3% of all childhood cancers but is the most common intraocular malignancy in children. With improved awareness, early screening, and advances in treatment, survival rates in developed nations exceed 90%. However, challenges remain in low- and middle-income countries where delayed diagnosis and limited access to…
Ophthalmic Treatment Demand Fuels Growth In Retinoblastoma Treatment Market: Key …
The Retinoblastoma Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Retinoblastoma Treatment Market Size During the Forecast Period?
The retinoblastoma treatment market, worth $2.03 billion in 2024, will grow to $2.16 billion in 2025 at a CAGR of 6.2%. Growth has…
Major Market Shift in Retinoblastoma Treatment Industry: Innovative Oncolytic Ad …
What Is the Forecasted Market Size and Growth Rate for the Retinoblastoma Treatment Market?
In the past few years, the market size for retinoblastoma treatment has displayed robust growth. It is expected to surge from a value of $2.03 billion in 2024 to $2.16 billion in 2025, with a compound annual growth rate (CAGR) standing at 6.2%. The growth during the previous period can be ascribed to factors such as an…
Major Market Shift in Retinoblastoma Treatment Industry: Innovative Oncolytic Ad …
"What Is the Forecasted Market Size and Growth Rate for the Retinoblastoma Treatment Market?
In the past few years, the market size for retinoblastoma treatment has displayed robust growth. It is expected to surge from a value of $2.03 billion in 2024 to $2.16 billion in 2025, with a compound annual growth rate (CAGR) standing at 6.2%. The growth during the previous period can be ascribed to factors such as an…
Retinoblastoma Treatment Market Size 2024 to 2031.
Market Overview and Report Coverage
Retinoblastoma is a rare cancer of the eye that primarily affects young children. The global Retinoblastoma Treatment Market is expected to grow at a CAGR of 10.00% during the forecasted period. The key drivers for this growth include advancements in technology, increasing awareness about early detection and treatment, as well as improvements in healthcare infrastructure in developing countries.
Currently, the market for Retinoblastoma treatment is…
